| Date Filed | Type | Description |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2023 |
4
| KARBE FRANK (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 09/15/2022 |
4
| KARBE FRANK (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $2.0939, valued at
$104.7k
|
|
| 07/07/2022 |
4
| KARBE FRANK (See Remarks) has filed a Form 4 on Better Therapeutics, Inc.|
Txns:
| Granted 472,200 options to buy
@ $1.68, valued at
$793.3k
|
|
| 07/07/2022 |
3
| KARBE FRANK (See Remarks) has filed a Form 3 on Better Therapeutics, Inc. |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2022 |
4
| KARBE FRANK (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $13.61, valued at
$272.2k
|
|
| 04/26/2022 |
3
| KARBE FRANK (Director) has filed a Form 3 on Phathom Pharmaceuticals, Inc. |
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 750 shares
@ $21.4, valued at
$16.1k
Exercised 750 options to buy
@ $5.11, valued at
$3.8k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 750 shares
@ $21.5, valued at
$16.1k
Exercised 750 options to buy
@ $5.11, valued at
$3.8k
|
|
| 12/30/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 11,800 shares
@ $30, valued at
$354k
Exercised 11,800 options to buy
@ $5.11, valued at
$60.3k
|
|
| 12/17/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 380 shares
@ $23.6321, valued at
$9k
Sold 670 shares
@ $24.4515, valued at
$16.4k
Exercised 1,050 options to buy
@ $5.11, valued at
$5.4k
|
|
| 12/02/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 1,500 shares
@ $24, valued at
$36k
Exercised 1,500 options to buy
@ $5.11, valued at
$7.7k
|
|
| 11/19/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 750 shares
@ $20, valued at
$15k
Exercised 750 options to buy
@ $5.11, valued at
$3.8k
|
|
| 11/17/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 750 shares
@ $20, valued at
$15k
Exercised 750 options to buy
@ $5.11, valued at
$3.8k
|
|
| 09/17/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 750 shares
@ $21.73, valued at
$16.3k
Exercised 750 options to buy
@ $5.11, valued at
$3.8k
|
|
| 09/01/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 3,650 shares
@ $20.04, valued at
$73.1k
Sold 21,150 shares
@ $20.013, valued at
$423.3k
Exercised 3,650 options to buy
@ $5.11, valued at
$18.7k
Exercised 21,150 options to buy
@ $5.11, valued at
$108.1k
|
|
| 08/21/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Sold 700 shares
@ $20, valued at
$14k
Exercised 700 options to buy
@ $5.11, valued at
$3.6k
|
|
| 05/28/2020 |
4
| KARBE FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 30,000 options to buy
@ $3, valued at
$90k
|
|
| 04/07/2020 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 120,146 shares
@ $0
Granted 183,991 options to buy
@ $8.08, valued at
$1.5M
|
|
| 12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/27/2019 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 55,025 shares
@ $0
Disposed/sold 200,000 options to buy
@ $12.68, valued at
$2.5M
Granted 200,000 options to buy
@ $7.78, valued at
$1.6M
Disposed/sold 114,690 options to buy
@ $21.87, valued at
$2.5M
Granted 114,690 options to buy
@ $7.78, valued at
$892.3k
Disposed/sold 132,270 options to buy
@ $24.44, valued at
$3.2M
Granted 132,270 options to buy
@ $7.78, valued at
$1M
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2019 |
4
| KARBE FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.29, valued at
$98.7k
|
|
| 05/08/2019 |
3/A
| KARBE FRANK (Director) has filed a Form 3/A on ADURO BIOTECH, INC. |
| 04/19/2019 |
4
| KARBE FRANK (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 60,000 options to buy
@ $3.38, valued at
$202.8k
|
|
| 04/19/2019 |
3
| KARBE FRANK (Director) has filed a Form 3 on ADURO BIOTECH, INC. |
| 04/09/2019 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 132,270 options to buy
@ $24.44, valued at
$3.2M
|
|
| 04/18/2018 |
4
| KARBE FRANK (Principal Fin'l & Accounting) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 114,690 options to buy
@ $21.87, valued at
$2.5M
|
|
| 06/23/2017 |
4
| KARBE FRANK (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options to buy
@ $3.55, valued at
$78.1k
|
|
|